DAVID M MOTT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID M MOTT.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is a Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and a 10% Owner in ARCA biopharma, Inc. ($ABIO) and a 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and a 10% Owner in Achaogen Inc ($AKAO) and a 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and a 10% Owner in MULESOFT, INC ($MULE) and a 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and a 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and a 10% Owner in Care.com Inc ($CRCM) and a Director in ARDELYX, INC. ($ARDX) and a 10% Owner in APPIAN CORP ($APPN) and a Director in Mersana Therapeutics, Inc. ($MRSN) and a 10% Owner in Roka BioScience, Inc. ($ROKA) and a 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and a Director in TESARO, Inc. ($TSRO) and a 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and a 10% Owner in Cerecor Inc. ($CERC) and a Director in Epizyme, Inc. ($EPZM) and a Director in Adaptimmune Therapeutics PLC ($ADAP) and a 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a 10% Owner in Elastic N.V. ($ESTC) and a Director in Nightstar Therapeutics plc ($NITE) and a 10% Owner in Surface Oncology, Inc. ($SURF).

Over the past year DAVID M MOTT has been an insider in 10 companies. The total value of shares held by DAVID M MOTT in these companies amounts to $469,872,547.

DAVID M MOTT 10% Owner
Achaogen, Inc.
Director
Adaptimmune Therapeutics PLC
10% Owner
APPIAN CORP
10% Owner
ARCA biopharma, Inc.
Director
ARDELYX, INC.
10% Owner
AVEO PHARMACEUTICALS INC
10% Owner
Care.com Inc
10% Owner
Cascadian Therapeutics, Inc.
10% Owner
Cerecor Inc.
10% Owner
Elastic N.V.
Director
Epizyme, Inc.
10% Owner
INTERLEUKIN GENETICS INC
Vice Chairman and CEO
MEDIMMUNE INC /DE
Director
Mersana Therapeutics, Inc.
10% Owner
MULESOFT, INC
Director
Nightstar Therapeutics plc
10% Owner
Ra Pharmaceuticals, Inc.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
10% Owner
Sorrento Tech, Inc.
10% Owner
Surface Oncology, Inc.
10% Owner
SYNLOGIC, INC.
Director
TESARO, Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
$ 469872547 The total value of shares held by DAVID M MOTT
Insider Rank

DAVID M MOTT ranks 177 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 35 WEST WATKINS MILL ROAD GAITHERSBURG 20878 MD

Companies in which DAVID M MOTT is an Insider

Achaogen, Inc.

Trading Symbol: AKAO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 5,215,128 shares
Current Value: $98,305,163
Latest Transaction: Dec 19 2016
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 500,000
Shares Sold: 0
Share Difference: +500,000
Value Difference: -$6,750,000

Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Director
Holdings: 82,978,668 shares
Current Value: $375,893,366
Latest Transaction: Sep 10 2018
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 35,709,672
Shares Sold: 0
Share Difference: +35,709,672
Value Difference: -$49,015,100

APPIAN CORP

Trading Symbol: APPN
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DAVID M MOTT: 10% Owner
Holdings: 2,724,202 shares
Latest Transaction: Feb 15 2018

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 9x
Sell: 5x
Shares Bought: 6,171,127
Shares Sold: 6,155,201
Share Difference: +15,926
Value Difference: +$66,073,750

ARCA biopharma, Inc.

Trading Symbol: ABIO
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID M MOTT: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 27 2018
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 1x
Shares Bought: 0
Shares Sold: 1,460,209
Share Difference: -1,460,209
Value Difference: +$731,273

ARDELYX, INC.

Trading Symbol: ARDX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 54,720 shares
Current Value: $604,656
Latest Transaction: Jun 15 2018
$ARDX Market Capitalization: $529.77M
$ARDX Previous Close: $11.05

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 13x
Sell: 0x
Shares Bought: 6,991,436
Shares Sold: 0
Share Difference: +6,991,436
Value Difference: -$56,666,684

AVEO PHARMACEUTICALS INC

Trading Symbol: AVEO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 25,243,865 shares
Current Value: $15,398,758
Latest Transaction: Apr 08 2019
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 28x
Sell: 0x
Shares Bought: 15,051,171
Shares Sold: 0
Share Difference: +15,051,171
Value Difference: -$17,457,594

Care.com Inc

Trading Symbol: CRCM
Industry: SERVICES-PERSONAL SERVICES [7200]
Position of DAVID M MOTT: 10% Owner
Holdings: 2,256,013 shares
Current Value: $21,071,161
Latest Transaction: Nov 08 2017
$CRCM Market Capitalization: $283.29M
$CRCM Previous Close: $9.34

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 2x
Shares Bought: 12,806
Shares Sold: 1,010,000
Share Difference: -997,194
Value Difference: $0

Cascadian Therapeutics, Inc.

Trading Symbol: CASC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of DAVID M MOTT: 10% Owner
Holdings: 0 shares
Latest Transaction: Mar 13 2018

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 1x
Shares Bought: 0
Shares Sold: 10,882,574
Share Difference: -10,882,574
Value Difference: $0

Cerecor Inc.

Trading Symbol: CERC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 594,245 shares
Current Value: $493,223
Latest Transaction: Oct 20 2015
$CERC Market Capitalization: $7.38M
$CERC Previous Close: $0.83

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Elastic N.V.

Trading Symbol: ESTC
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DAVID M MOTT: 10% Owner
Holdings: 4,155,995 shares
Latest Transaction: Oct 10 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 5,684,112
Shares Sold: 0
Share Difference: +5,684,112
Value Difference: $0

Epizyme, Inc.

Trading Symbol: EPZM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 6,471,018 shares
Current Value: $77,975,767
Latest Transaction: Oct 05 2018
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 628,755
Shares Sold: 0
Share Difference: +628,755
Value Difference: -$6,944,475

INTERLEUKIN GENETICS INC

Trading Symbol: ILIU
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID M MOTT: 10% Owner
Holdings: 55,418,811 shares
Current Value: $5,541,881
Latest Transaction: Aug 02 2016
$ILIU Market Capitalization: $22.11M
$ILIU Previous Close: $0.10

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 20,120,724
Shares Sold: 0
Share Difference: +20,120,724
Value Difference: -$2,000,000

MEDIMMUNE INC /DE

Trading Symbol: MEDI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Vice Chairman and CEO
Holdings: 0 shares
Latest Transaction: Mar 10 2004

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Mersana Therapeutics, Inc.

Trading Symbol: MRSN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 11,890,138 shares
Latest Transaction: Mar 06 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 11,890,138
Shares Sold: 0
Share Difference: +11,890,138
Value Difference: -$30,000,000

MULESOFT, INC

Trading Symbol: MULE
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DAVID M MOTT: 10% Owner
Holdings: 12,679,970 shares
Latest Transaction: May 09 2018

Last 4 weeks trend: SELL
Last 3 months trend: SELL View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 6x
Shares Bought: 31,910,994
Shares Sold: 32,231,774
Share Difference: -320,780
Value Difference: $0

Nightstar Therapeutics plc

Trading Symbol: NITE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Director
Holdings: 0 shares
Latest Transaction: Jan 29 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ra Pharmaceuticals, Inc.

Trading Symbol: RARX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 80,658 shares
Current Value: $1,465,556
Latest Transaction: Oct 31 2016
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 1x
Shares Bought: 3,490,508
Shares Sold: 435
Share Difference: +3,490,073
Value Difference: -$4,399,997

RHYTHM PHARMACEUTICALS, INC.

Trading Symbol: RYTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 1,432,248 shares
Latest Transaction: Oct 10 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 4,880,578
Shares Sold: 0
Share Difference: +4,880,578
Value Difference: -$9,350,000

Sorrento Tech, Inc.

Trading Symbol: ROKA
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of DAVID M MOTT: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 23 2016
$ROKA Market Capitalization: $8.04M
$ROKA Previous Close: $4.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Surface Oncology, Inc.

Trading Symbol: SURF
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: 10% Owner
Holdings: 3,179,544 shares
Latest Transaction: Apr 23 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 6,625,754
Shares Sold: 0
Share Difference: +6,625,754
Value Difference: -$3,999,990

SYNLOGIC, INC.

Trading Symbol: SYBX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 4,228,940 shares
Current Value: $9,303,668
Latest Transaction: Jan 26 2018
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 3,804,439
Shares Sold: 0
Share Difference: +3,804,439
Value Difference: -$3,997,500

TESARO, Inc.

Trading Symbol: TSRO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 22 2019
$TSRO Market Capitalization: $8.41B
$TSRO Previous Close: $162.95

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 21x
Sell: 4x
Shares Bought: 1,571,718
Shares Sold: 10,437,250
Share Difference: -8,865,532
Value Difference: +$724,439,552

Tracon Pharmaceuticals, Inc.

Trading Symbol: TCON
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: 10% Owner
Holdings: 3,466,003 shares
Current Value: $17,156,715
Latest Transaction: Mar 27 2018
$TCON Market Capitalization: $64.02M
$TCON Previous Close: $4.95

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 1,577,529
Shares Sold: 0
Share Difference: +1,577,529
Value Difference: -$6,911,502

Latest Insider Trading Transactions of DAVID M MOTT

Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, ILIU, MEDI, MRSN, MULE, NITE, RARX, RYTM, ROKA, SURF, SYBX, TSRO, TCON

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 08 2019AVEOAVEO PHARMACEUTICA ...MOTT DAVID M10% OwnerOption ExerciseP1.254,347,8275,434,7844,347,827
Apr 08 2019AVEOAVEO PHARMACEUTICA ...MOTT DAVID M10% OwnerBuyP1.144,347,8274,956,52325,243,86520.9 M to 25.2 M (+20.81 %)
Mar 06 2019MRSNMersana Therapeuti ...MOTT DAVID MDirectorBuyP4.003,750,00015,000,00011,890,1388.1 M to 11.9 M (+46.07 %)
Jan 29 2019NITENightstar Therapeu ...MOTT DAVID MDirectorOption ExerciseA13.5721,000284,97021,000
Jan 29 2019NITENightstar Therapeu ...MOTT DAVID MDirectorOption ExerciseA13.5721,000284,97021,000
Jan 22 2019TSROTESARO, Inc.MOTT DAVID MDirectorOption ExerciseD46.897,290341,8280
Jan 22 2019TSROTESARO, Inc.MOTT DAVID MDirectorOption ExerciseD149.2212,0001,790,6400

View all DAVID M MOTT insider transactions.